{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:16:26Z","timestamp":1790396186865,"version":"4.1.0"},"reference-count":61,"publisher":"The Endocrine Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The progesterone receptor (PR) plays roles in normal mammary development and breast cancer formation, where it may exert both stimulatory and inhibitory actions. Previously, the breast cancer susceptibility gene product BRCA1 was found to interact with and inhibit the transcriptional activity of estrogen receptor-\u03b1. In this study, we found that exogenous wild-type BRCA1 inhibited the activity of the PR in transient transfection assays utilizing a mouse mammary tumor virus-Luc reporter. Wild-type BRCA1 inhibited the activity of endogenous PR in human breast cancer cells (T47D and MCF-7) and inhibited the activity of exogenous PR-A, PR-B, and [PR-A plus PR-B] isoforms. On the other hand, knockdown of endogenous BRCA1 using small interfering RNA enhanced the progesterone-stimulated activity of the PR by about 4-fold. We documented an in vivo association of the endogenous BRCA1 with PR isoforms A and B and a direct in vitro interaction between BRCA1 and PR, which was partially mapped. Whereas down-regulation of the coactivator p300 contributes to the BRCA1-mediated repression of estrogen receptor-\u03b1, this mechanism does not contribute to inhibition of PR activity, because exogenous p300 did not rescue the BRCA1 repression of PR activity. The BRCA1-PR interaction has functional consequences. Thus, we showed that BRCA1 inhibits the expression of various endogenous progesterone-responsive genes and inhibits progesterone-stimulated proliferation of T47D cells. Finally, exogenous progesterone caused an exaggerated proliferative response in the mammary glands of mice harboring a mammary-targeted conditional deletion of the full-length isoform of Brca1. These findings suggest that BRCA1 regulates the activity of progesterone, a major hormone of pregnancy that may also participate in mammary carcinogenesis.<\/jats:p>","DOI":"10.1210\/me.2004-0488","type":"journal-article","created":{"date-parts":[[2005,8,19]],"date-time":"2005-08-19T00:14:13Z","timestamp":1124410453000},"page":"14-34","source":"Crossref","is-referenced-by-count":92,"title":["The Breast Cancer Susceptibility Gene BRCA1 Regulates Progesterone Receptor Signaling in Mammary Epithelial Cells"],"prefix":"10.1210","volume":"20","author":[{"given":"Yongxian","family":"Ma","sequence":"first","affiliation":[{"name":"Department of Oncology, Lombardi Cancer Center, Georgetown University, Washington, D.C. 20057-1469"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pragati","family":"Katiyar","sequence":"additional","affiliation":[{"name":"Department of Oncology, Lombardi Cancer Center, Georgetown University, Washington, D.C. 20057-1469"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laundette P.","family":"Jones","sequence":"additional","affiliation":[{"name":"Department of Oncology, Lombardi Cancer Center, Georgetown University, Washington, D.C. 20057-1469"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saijun","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Oncology, Lombardi Cancer Center, Georgetown University, Washington, D.C. 20057-1469"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Lombardi Cancer Center, Georgetown University, Washington, D.C. 20057-1469"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla A.","family":"Furth","sequence":"additional","affiliation":[{"name":"Department of Oncology, Lombardi Cancer Center, Georgetown University, Washington, D.C. 20057-1469"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliot M.","family":"Rosen","sequence":"additional","affiliation":[{"name":"Department of Oncology, Lombardi Cancer Center, Georgetown University, Washington, D.C. 20057-1469"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071614484642900_R1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","article-title":"A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.","volume":"266","author":"Miki","year":"1994","journal-title":"Science"},{"key":"2020071614484642900_R2","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0140-6736(94)91578-4","article-title":"Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.","volume":"343","author":"Ford","year":"1994","journal-title":"Lancet"},{"key":"2020071614484642900_R3","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1056\/NEJM199705153362001","article-title":"The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.","volume":"336","author":"Streuwing","year":"1997","journal-title":"N Engl J Med"},{"key":"2020071614484642900_R4","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/jnci\/94.18.1358","article-title":"Cancer incidence in BRCA1 mutation carriers.","volume":"94","author":"Thompson","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"2020071614484642900_R5","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.tem.2003.08.001","article-title":"BRCA1 in hormone responsive cancers.","volume":"14","author":"Rosen","year":"2003","journal-title":"Trends Endocrinol Metab"},{"key":"2020071614484642900_R6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/jcp.10257","article-title":"The BRCA1 gene in breast cancer.","volume":"196","author":"Rosen","year":"2003","journal-title":"J Cell Physiol"},{"key":"2020071614484642900_R7","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1126\/science.284.5418.1354","article-title":"BRCA1 inhibits estrogen receptor signaling in transfected cells.","volume":"284","author":"Fan","year":"1999","journal-title":"Science"},{"key":"2020071614484642900_R8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/sj.onc.1204073","article-title":"2001 Role of direct interaction in BRCA1 inhibition of estrogen receptor activity.","volume":"20","author":"Fan","year":"2001","journal-title":"Oncogene"},{"key":"2020071614484642900_R9","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1210\/en.2004-0409","article-title":"Regulation of the estrogen-inducible gene expression profile by the breast cancer susceptibility gene BRCA1.","volume":"146","author":"Xu","year":"2005","journal-title":"Endocrinology"},{"key":"2020071614484642900_R10","first-page":"141","article-title":"p300 modulates BRCA1 inhibition of estrogen receptor activity.","volume":"62","author":"Fan","year":"2002","journal-title":"Cancer Res"},{"key":"2020071614484642900_R11","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1038\/sj.onc.1208190","article-title":"Structural determinants of the BRCA1: estrogen receptor interaction.","volume":"24","author":"Ma","year":"2005","journal-title":"Oncogene"},{"key":"2020071614484642900_R12","doi-asserted-by":"crossref","first-page":"9587","DOI":"10.1073\/pnas.171174298","article-title":"BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor.","volume":"98","author":"Zheng","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071614484642900_R13","doi-asserted-by":"crossref","first-page":"7730","DOI":"10.1038\/sj.onc.1205971","article-title":"Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells.","volume":"21","author":"Kawai","year":"2002","journal-title":"Oncogene"},{"key":"2020071614484642900_R14","doi-asserted-by":"crossref","first-page":"11256","DOI":"10.1073\/pnas.190353897","article-title":"Increase of androgen-induced cell death and androgen receptor transactivation by BRCA1 in prostate cancer cells.","volume":"97","author":"Yeh","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071614484642900_R15","first-page":"5946","article-title":"Breast cancer susceptibility gene 1 (BRCAI) is a coactivator of the androgen receptor.","volume":"60","author":"Park","year":"2000","journal-title":"Cancer Res"},{"key":"2020071614484642900_R16","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.steroids.2003.09.004","article-title":"Two pathways of progesterone action in the human endometrium: implications for implantation and contraception.","volume":"68","author":"Lessey","year":"2003","journal-title":"Steroids"},{"key":"2020071614484642900_R17","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/S1357-2725(03)00030-X","article-title":"Transcriptional regulators in mammary gland development and cancer.","volume":"35","author":"Visvader","year":"2003","journal-title":"Int J Biochem Cell Biol"},{"key":"2020071614484642900_R18","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1742-1241.2002.tb11372.x","article-title":"20 Oral contraceptives, hormone replacement therapy and breast cancer.","volume":"56","author":"Fentiman","year":"2002","journal-title":"Int J Clin Pract"},{"key":"2020071614484642900_R19","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1034\/j.1600-0463.2001.090501.x","article-title":"Epidemiology of breast cancer: an environmental disease?","volume":"109","author":"Sasco","year":"2001","journal-title":"APMIS"},{"key":"2020071614484642900_R20","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3109\/07435808909036347","article-title":"Protein-DNA interactions at steroid hormone regulated genes.","volume":"15","author":"Scheidereit","year":"1989","journal-title":"Endocr Res"},{"key":"2020071614484642900_R21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0303-7207(94)90096-5","article-title":"Synthetic progestins induce proliferation of breast tumor cell lines via the progesterone or estrogen receptor.","volume":"102","author":"Kalkhoven","year":"1994","journal-title":"Mol Cell Endocrinol"},{"key":"2020071614484642900_R22","doi-asserted-by":"crossref","first-page":"8668","DOI":"10.1128\/MCB.23.23.8668-8690.2003","article-title":"BRCA1 inhibition of telomerase activity in cultured cells.","volume":"23","author":"Xiong","year":"2003","journal-title":"Mol Cell Biol"},{"key":"2020071614484642900_R23","doi-asserted-by":"crossref","first-page":"7893","DOI":"10.1158\/0008-5472.CAN-04-1119","article-title":"BRCA1 induces antioxidant gene expression and resistance to oxidative stress.","volume":"64","author":"Bae","year":"2004","journal-title":"Cancer Res"},{"key":"2020071614484642900_R24","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1128\/MCB.23.6.1994-2008.2003","article-title":"Two domains of the progesterone receptor interact with the estrogen receptor and are required for progesterone activation of the c-Src\/Erk pathway in mammalian cells.","volume":"23","author":"Ballare","year":"2003","journal-title":"Mol Cell Biol"},{"key":"2020071614484642900_R25","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1038\/sj.onc.1202116","article-title":"BRCA1 as a human prostate tumor suppressor: modulation of proliferation, damage responses, and expression of regulatory proteins.","volume":"16","author":"Fan","year":"1998","journal-title":"Oncogene"},{"key":"2020071614484642900_R26","doi-asserted-by":"crossref","first-page":"5209","DOI":"10.1074\/jbc.M110090200","article-title":"Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells.","volume":"277","author":"Richer","year":"2002","journal-title":"J Biol Chem"},{"key":"2020071614484642900_R27","first-page":"8022","article-title":"Altered gene expression pattern in cultured human breast cancer cells treated with hepatocyte growth factor\/scatter factor in the setting of DNA damage.","volume":"61","author":"Yuan","year":"2001","journal-title":"Cancer Res"},{"key":"2020071614484642900_R28","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/8743","article-title":"Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation.","volume":"22","author":"Xu","year":"1999","journal-title":"Nat Genet"},{"key":"2020071614484642900_R29","doi-asserted-by":"crossref","first-page":"7514","DOI":"10.1038\/sj.onc.1204929","article-title":"Multiple genetic changes are associated with mammary tumorigenesis in Brca1 conditional knockout mice.","volume":"20","author":"Brodie","year":"2001","journal-title":"Oncogene"},{"key":"2020071614484642900_R30","doi-asserted-by":"crossref","first-page":"5097","DOI":"10.1038\/sj.onc.1205636","article-title":"Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer.","volume":"21","author":"Weaver","year":"2002","journal-title":"Oncogene"},{"key":"2020071614484642900_R31","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/em.10069","article-title":"Tumor formation in Brca1 conditional mutant mice.","volume":"39","author":"Deng","year":"2002","journal-title":"Environ Mol Mutagen"},{"key":"2020071614484642900_R32","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1038\/sj.onc.1208426","article-title":"Promotion of mammary cancer development by tamoxifen in a mouse model of Brca1-mutation-related breast cancer.","volume":"24","author":"Jones","year":"2005","journal-title":"Oncogene"},{"key":"2020071614484642900_R33","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1210\/mend.12.12.0210","article-title":"Agonist and antagonists induce homodimerization and mixed ligand heterodimerization of human progesterone receptors in vivo by a mammalian two-hybrid assay.","volume":"12","author":"Leonhardt","year":"1998","journal-title":"Mol Endocrinol"},{"key":"2020071614484642900_R34","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1210\/mend.11.8.9963","article-title":"Hinge and amino-terminal sequences contribute to solution dimerization of human progesterone receptor.","volume":"11","author":"Tetel","year":"1997","journal-title":"Mol Endocrinol"},{"key":"2020071614484642900_R35","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng0995-17","article-title":"The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues.","volume":"11","author":"Marquis","year":"1995","journal-title":"Nat Genet"},{"key":"2020071614484642900_R36","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1101\/gad.9.21.2712","article-title":"Expression of Brca1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice.","volume":"9","author":"Lane","year":"1995","journal-title":"Genes Dev"},{"key":"2020071614484642900_R37","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1006\/dbio.1997.8526","article-title":"Developmental expression of Brca2 colocalizes with Brca1 and is associated with proliferation and differentiation in multiple tissues.","volume":"184","author":"Rajan","year":"1997","journal-title":"Dev Biol"},{"key":"2020071614484642900_R38","doi-asserted-by":"crossref","first-page":"11697","DOI":"10.1073\/pnas.95.20.11697","article-title":"1998 Distinct steady-state nuclear receptor coregulator complexes exist in vivo.","volume":"95","author":"McKenna","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071614484642900_R39","doi-asserted-by":"crossref","first-page":"12426","DOI":"10.1073\/pnas.231474798","article-title":"Sequential recruitment of steroid receptor coactivator-1 (SRC-1) and p300 enhances progesterone receptor-dependent initiation and reinitiation of transcription from chromatin.","volume":"98","author":"Liu","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071614484642900_R40","doi-asserted-by":"crossref","first-page":"8884","DOI":"10.1073\/pnas.93.17.8884","article-title":"CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent transcription.","volume":"93","author":"Smith","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071614484642900_R41","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/bcr540","article-title":"Progesterone receptors\u2014animal models and cell signalling in breast cancer. Implications for breast cancer of inclusion of progestins in hormone replacement therapies.","volume":"4","author":"Schairer","year":"2002","journal-title":"Breast Cancer Res"},{"key":"2020071614484642900_R42","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1023\/A:1025952924864","article-title":"Progesterone receptors in mammary gland development and tumorigenesis.","volume":"8","author":"Conneely","year":"2003","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"2020071614484642900_R43","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1210\/endo.140.6.6634","article-title":"A mouse model to study the effects of hormone replacement therapy on normal mammary gland during menopause: enhanced proliferative response to estrogen in late postmenopausal mice.","volume":"140","author":"Raafat","year":"1999","journal-title":"Endocrinology"},{"key":"2020071614484642900_R44","doi-asserted-by":"crossref","first-page":"13078","DOI":"10.1073\/pnas.93.23.13078","article-title":"Brca2 is coordinately regulated with Brca1 during proliferation and differentiation in mammary epithelial cells.","volume":"93","author":"Rajan","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071614484642900_R45","doi-asserted-by":"crossref","first-page":"4747","DOI":"10.1038\/sj.onc.1205580","article-title":"Brca1 regulates in vitro differentiation of mammary epithelial cells.","volume":"21","author":"Kubista","year":"2002","journal-title":"Oncogene"},{"key":"2020071614484642900_R46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3835(01)00507-9","article-title":"Short-term exposure to estrogen and progesterone induces partial protection against N-nitroso-N-methylurea-induced mammary tumorigenesis in Wistar-Furth rats.","volume":"169","author":"Medina","year":"2001","journal-title":"Cancer Lett"},{"key":"2020071614484642900_R47","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/carcin\/20.4.623","article-title":"Protective effects of pregnancy and lactation against N-methyl-N-nitrosourea-induced mammary carcinomas in female Lewis rats.","volume":"20","author":"Yang","year":"1999","journal-title":"Carcinogenesis"},{"key":"2020071614484642900_R48","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1749-6632.2001.tb02726.x","article-title":"Hormonal prevention of hereditary breast cancer.","volume":"952","author":"Narod","year":"2001","journal-title":"Ann NY Acad Sci"},{"key":"2020071614484642900_R49","first-page":"2011","article-title":"Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based study.","volume":"59","author":"Armes","year":"1999","journal-title":"Cancer Res"},{"key":"2020071614484642900_R50","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1200\/JCO.2002.09.023","article-title":"The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.","volume":"20","author":"Lakhani","year":"2002","journal-title":"J Clin Oncol"},{"key":"2020071614484642900_R51","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1001\/jama.286.18.2251","article-title":"Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial.","volume":"286","author":"King","year":"2001","journal-title":"JAMA"},{"key":"2020071614484642900_R52","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMoa012158","article-title":"Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.","volume":"346","author":"Rebbeck","year":"2002","journal-title":"N Engl J Med"},{"key":"2020071614484642900_R53","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1158\/0008-5472.CAN-04-1283","article-title":"Increased progesterone receptor expression in benign epithelium of BRCA1-related breast cancers.","volume":"64","author":"King","year":"2004","journal-title":"Cancer Res"},{"key":"2020071614484642900_R54","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/(SICI)1097-0215(19980821)79:4<334::AID-IJC5>3.0.CO;2-W","article-title":"An important role for BRCA1 in breast cancer progression is indicated by its loss in a large proportion of non-familial breast cancers.","volume":"79","author":"Taylor","year":"1998","journal-title":"Int J Cancer"},{"key":"2020071614484642900_R55","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/6029","article-title":"Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas.","volume":"21","author":"Wilson","year":"1999","journal-title":"Nat Genet"},{"key":"2020071614484642900_R56","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/jnci\/92.7.564","article-title":"Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors.","volume":"92","author":"Esteller","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"2020071614484642900_R57","first-page":"4978","article-title":"Haplo-insufficiency of BRCA1 in sporadic breast cancer.","volume":"63","author":"Staff","year":"2003","journal-title":"Cancer Res"},{"key":"2020071614484642900_R58","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/nar\/11.5.1475","article-title":"Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.","volume":"5","author":"Dignam","year":"1983","journal-title":"Nucleic Acids Res"},{"key":"2020071614484642900_R59","doi-asserted-by":"crossref","first-page":"5208","DOI":"10.1073\/pnas.080469697","article-title":"Collaboration of signal transducer and activator of transcription 1 (STAT1) and BRCA1 in differential regulation of IFN-\u03b3 target genes.","volume":"97","author":"Ouchi","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071614484642900_R60","doi-asserted-by":"crossref","first-page":"4323","DOI":"10.1093\/nar\/25.21.4323","article-title":"Cre-mediated gene deletion in the mammary gland.","volume":"25","author":"Wagner","year":"1997","journal-title":"Nucleic Acids Res"},{"key":"2020071614484642900_R61","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1158\/0008-5472.681.65.3","article-title":"Deregulated estrogen receptor \u03b1 expression in mammary epithelial cells of transgenic mice results in the development of ductal carcinoma in situ.","volume":"65","author":"Frech","year":"2005","journal-title":"Cancer Res"}],"container-title":["Molecular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/mend\/article-pdf\/20\/1\/14\/8951381\/mend0014.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/mend\/article-pdf\/20\/1\/14\/8951381\/mend0014.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T07:12:47Z","timestamp":1683184367000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mend\/article\/20\/1\/14\/2741297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1,1]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1,1]]}},"URL":"https:\/\/doi.org\/10.1210\/me.2004-0488","relation":{},"ISSN":["0888-8809","1944-9917"],"issn-type":[{"value":"0888-8809","type":"print"},{"value":"1944-9917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,1,1]]}}}